Peregrine Capital Management LLC Argenx Se Transaction History
Peregrine Capital Management LLC
- $3.09 Billion
- Q3 2025
A detailed history of Peregrine Capital Management LLC transactions in Argenx Se stock. As of the latest transaction made, Peregrine Capital Management LLC holds 239 shares of ARGX stock, worth $199,505. This represents 0.01% of its overall portfolio holdings.
Number of Shares
239Holding current value
$199,505% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ARGX
# of Institutions
490Shares Held
28.1MCall Options Held
370KPut Options Held
211K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$4.16 Billion0.31% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$2.33 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.57MShares$2.14 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.63 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.18MShares$981 Million11.81% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $46.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...